Health Care Select Sector SPDR® Fund (XLV)

103.93
Delayed Data
As of Feb 14
 +0.08 / +0.08%
Today’s Change
84.10
Today|||52-Week Range
105.08
+2.03%
Year-to-Date

Investment Objective

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Is Ironwood Pharmaceuticals Stock a Buy?
Feb 12 / MotleyFool.com - Paid Partner Content
 

Performance

1 month+0.87% 3 years+14.62%
3 months+10.15% 5 years+9.81%
1 year+16.21% Since inception+8.72%
Data through 02/15/2020

Quote Details

Previous close$103.85
Open day’s range103.42 – 104.00
Net asset value (NAV)103.96 (02/14/2020)
Daily volume5,114,244
Average volume (3 months)7,998,322
Data as of 8:00pm ET, 02/14/2020

Peer Comparisonvs. Health ETFs

 XLVCategory
Performance 5-yr return+9.81%+8.75%
Expense Gross exp ratio0.13%1.26%
Risk 5 year sharpe ratio0.640.45
Net assets$19.5B$3.2B
Average market cap$101.8B$43.9B
Average P/E24.427.7
Dividend / Share--0.30%

Competitors

VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
IXJ iShares Global Healthcare ETF

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson10.62%
UNH UnitedHealth6.99%
MRK Merck5.89%
PFE Pfizer5.58%
MDT Medtronic PLC4.19%
ABT Abbott Laboratories4.17%
BMY Bristol-Myers Squibb4.00%
AMGN Amgen3.48%
TMO Thermo Fisher Scientific Inc3.40%
ABBV AbbVie3.25%